The effectiveness of therapy and the quality of life of patients with rheumatoid arthritis depending on the baseline treatment adherence

Nikitina N.M.; Egorova E.V.; Bogdalova L.R.; Ziyadullaev Sh.Kh.; Rebrov A.P.

doi:https://doi.org/10.17116/profmed20232605178

Nikitina N.M.

Saratov State Medical University named after V.I. Razumovsky

SPIN RSCI: 6661-1830
Scopus AuthorID: 24338688700
ORCID: 0000-0002-0313-1191

Egorova E.V.

Regional Clinical Hospital

ORCID: 0000-0003-2818-115X

Bogdalova L.R.

Saratov State Medical University named after V.I. Razumovsky

ORCID: 0000-0003-2818-115X

Ziyadullaev Sh.Kh.

Samarkand State Medical University

SPIN RSCI: 9453-3639
Scopus AuthorID: 57214598227
ORCID: 0000-0002-9309-3933

Rebrov A.P.

Saratov State Medical University named after V.I. Razumovsky

SPIN RSCI: 9574-2067
Scopus AuthorID: 7005047527
ORCID: 0000-0002-3463-7734

The effectiveness of therapy and the quality of life of patients with rheumatoid arthritis depending on the baseline treatment adherence

Authors:

Nikitina N.M., Egorova E.V., Bogdalova L.R., Ziyadullaev Sh.Kh., Rebrov A.P.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2023;26(5): 78‑84

DOI: 10.17116/profmed20232605178

Read: 2212 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nikitina NM, Egorova EV, Bogdalova LR, Ziyadullaev ShKh, Rebrov AP. The effectiveness of therapy and the quality of life of patients with rheumatoid arthritis depending on the baseline treatment adherence. Russian Journal of Preventive Medicine. 2023;26(5):78‑84. (In Russ.)
https://doi.org/10.17116/profmed20232605178

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the real-world effectiveness of therapy and quality of life (QoL) of patients with rheumatoid arthritis (RA) after one year of follow-up, depending on baseline compliance.

MATERIAL AND METHODS

The study included 132 females with confirmed RA (age 55.5±10.5 years, duration of RA 10.2 [4; 14] years), with moderate and high activity of RA (DAS 28 score of 5.0 [4.3; 5.8]). Clinical and laboratory examination was conducted: QoL assessment using HAQ questionnaire and EQ-5D. Pain was assessed on a visual analog scale (VAS), treatment adherence was evaluated using the questionnaire for qualitative assessment of adherence to Morisky-Green and the QAA-25 — questionnaire for quantitative assessment of adherence (according to N.A. Nikolaev). In 60 patients comparable in baseline characteristics of the disease with different levels of adherence, the examinations were carried out at baseline and after a year.

RESULTS

Low treatment adherence was shown by the Morisky-Green questionnaire in 68 (52.3%) of 132 and by the QAA-25 questionnaire in 33 (40.3%) of 82 females with RA. The least adherence to the recommendations for lifestyle modification was noted. Predictors of high treatment adherence were the young age of patients, a shorter duration of the disease, and a lower level of pain according to VAS. In patients with RA with initially low adherence to treatment after a year, an increase in the disease activity and a decrease in quality of life were noted, despite the therapy.

CONCLUSION

The relationships we have identified between baseline adherence, disease activity, and quality of life after one year of follow-up demonstrate the importance of considering baseline adherence. The least adherence was to lifestyle changes. Further research is needed on the factors affecting overall adherence and its components. The development of methods to increase treatment adherence can improve the effectiveness of therapy and the quality of life of patients with rheumatoid arthritis.

Keywords:

rheumatoid arthritis

treatment adherence

therapy effectiveness

quality of life

Authors:

Nikitina N.M.

Saratov State Medical University named after V.I. Razumovsky

SPIN RSCI: 6661-1830
Scopus AuthorID: 24338688700
ORCID: 0000-0002-0313-1191

Egorova E.V.

Regional Clinical Hospital

ORCID: 0000-0003-2818-115X

Bogdalova L.R.

Saratov State Medical University named after V.I. Razumovsky

ORCID: 0000-0003-2818-115X

Ziyadullaev Sh.Kh.

Samarkand State Medical University

SPIN RSCI: 9453-3639
Scopus AuthorID: 57214598227
ORCID: 0000-0002-9309-3933

Rebrov A.P.

Saratov State Medical University named after V.I. Razumovsky

SPIN RSCI: 9574-2067
Scopus AuthorID: 7005047527
ORCID: 0000-0002-3463-7734

Received:

14.11.2022

Accepted:

08.02.2023

Close metadata

References:

Galushko EA, Nasonov EL. Prevalence of rheumatic diseases in Russia. Al’manax klinicheskoj mediciny’ 2018;46(1):32-39. (In Russ.). https://doi.org/10.18786/2072-0505-2018-46-1-32-39
World Health Organisation. Adherence to Long-Term Therapies, Evidence for Action. Geneva: WHO; 2003.
Nikitina NM, Egorova EV, Melehina IF, Grigoryeva SN, Rebrov AP. Problems of treatment adherence in patients with rheumatoid arthritis and comorbidity. Arxiv vnutrennej mediciny. 2020;10(5):372-381. (In Russ.). https://doi.org/10.20514/2226-6704-2020-10-5-372-381
Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina O.M. Questionnaires and scores for assessing medication adherence — advantages and disadvantages of the diagnostic method in research and actual clinical practice. Kardiovaskulyarnaya terapiya i profilaktika. 2020;19(3):2562. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2562
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medical adherence. Medical Care. 1986;24(1):67-73. https://doi.org/10.1097/00005650-198601000-00007
Nikolaev NA. Rukovodstvo po klinicheskim issledovanijam vnutrennih boleznej (nauchnaja monografija). M.: Izdatel’stvo Rosssijskoj akademii estestvennoj istorii, 2015. (In Russ.).
Nikolaev NA, Skirdenko YuP. Russian universal questionnaire for the quantitative evaluation of adherence to treatment (QEA-25). Klinicheskaya farmakologiya i terapiya. 2018;27(1):74-78. (In Russ.).
Postnikova PO, Kovalenko PS, Dydykina IS, Aboleshina AV, Lila AM. Analysis of adherence to treatment in patients with rheumatoid arthritis. Sovremennaya revmatologiya. 2022;16(4):40-45. (In Russ.). https://doi.org/10.14412/1996-7012-2022-4-40-45
Abramkin AA, Lisitsyna TA, Veltishchev DYu, Seravina OF, Kovalevskaya OB, Glukhova SI, Nasonov EL. Factors influencing the efficiency of therapy in patients with rheumatoid arthritis: the role of comorbid mental and somatic diseases. Nauchno-prakticheskaya revmatologiya. 2018;56(4):439-448. (In Russ.).
Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, Emery P, Landewé R, Oliver S, Aletaha D, Betteridge N, Braun J, Burmester G, Cañete JD, Damjanov N, FitzGerald O, Haglund E, Helliwell P, Kvien TK, Lories R, Luger T, Maccarone M, Marzo-Ortega H, McGonagle D, McInnes IB, Olivieri I, Pavelka K, Schett G, Sieper J, van den Bosch F, Veale DJ, Wollenhaupt J, Zink A, van der Heijde D. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Annals of the Rheumatic Diseases. 2016;75(3):499-510. https://doi.org/10.1136/annrheumdis-2015-208337
Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Schoels M, Sieper J, Wit Md, Baraliakos X, Betteridge N, Burgos-Vargas R, Collantes-Estevez E, Deodhar A, Elewaut D, Gossec L, Jongkees M, Maccarone M, Redlich K, van den Bosch F, Wei JC, Winthrop K, van der Heijde D. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Annals of the Rheumatic Diseases. 2014;73(1):6-16. https://doi.org/10.1136/annrheumdis-2013-203419
Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Annals of the Rheumatic Diseases. 2010;69(4):631-637. https://doi.org/10.1136/ard.2009.123919
Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Millán I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis and Rheumatology. 2021;73(7): 1108-1123. https://doi.org/10.1002/art.41752
Nasonov EL. Pharmacotherapy of rheumatoid arthritis: Russian and international recommendations. Nauchno-prakticheskaya revmatologiya. 2016; 54(5):557-571. (In Russ.). https://doi.org/10.14412/1995-4484-2016-557-571
Gordeev AV, Matyanova EV, Olyunin YuA, Galushko EA, Zotkin EG. Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look. Sovremennaya revmatologiya. 2022;16(2):13-20. (In Russ.). https://doi.org/10.14412/1996-7012-2022-2-13-20
Nasonov EL, Olyunin YuA, Lila AM. Rheumatoid arthritis: the problems of remission and therapy resistanse. Nauchno-prakticheskaya revmatologiya. 2018;56(3):263-271. (In Russ.). https://doi.org/10.14412/1995-4484-2018-263-271
Gordeev AV, Olyunin YuA, Galushko EA, Zotkin EG, Lila AM. Difficult-to-treat rheumatoid arthritis. What is it? Sovremennaya revmatologiya. 2021; 15(5):7-11. (In Russ.). https://doi.org/10.14412/1996-7012-2021-5-7-11
De Wit MP, Smolen JS, Gossec L, van der Heijde DM. Treating rheumatoid arthritis to target: the patient version of the international recommendations. Annals of the Rheumatic Diseases. 2011;70(6):891-895. https://doi.org/10.1136/ard.2010.146662
Souto A, Maneiro JR, Gómez-Reino JJ. Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases. Rheumatology. 2016;55(3):523-534. https://doi.org/10.1093/rheumatology/kev374
Nakagawa S, Nakaishi M, Hashimoto M, Ito H, Yamamoto W, Nakashima R, Tanaka M, Fujii T, Omura T, Imai S, Nakagawa T, Yonezawa A, Imai H, Mimori T, Matsubara K. Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis. PLoS One. 2018; 13(11):e0206943. https://doi.org/10.1371/journal.pone.0206943
Scheiman-Elazary A, Duan L, Shourt C, Agrawal H, Ellashof D, Cameron-Hay M, Furst DE. The rate of adherence to antiarthritis medications and associated factors among patients with rheumatoid arthritis: A systematic literature review and metaanalysis. The Journal of Rheumatology. 2016;43(3): 512-523. https://doi.org/10.3899/jrheum.141371
Curtis JR, Bykerk VP, Aassi M, Schiff M. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. The Journal of Rheumatology. 2016;43(11):1997-2009. https://doi.org/10.3899/jrheum.151212
Salaffi F, Carotti M, Di Carlo M, Farah S, Gutierrez M. Adherence to Anti-Tumor Necrosis Factor Therapy Administered Subcutaneously and Associated Factors in Patients with Rheumatoid Arthritis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases. 2015; 21(8):419‐425. https://doi.org/10.1097/RHU.0000000000000320
Gadallah MA, Boulos DN, Gebrel A, Dewedar S, Morisky DE. Assessment of rheumatoid arthritis patients’ adherence to treatment. The American Journal of the Medical Sciences. 2015;349(2):151‐156. https://doi.org/10.1097/MAJ.0000000000000376
Betegnie AL, Gauchet A, Lehmann A, Grange L, Roustit M, Baudrant M, Bedouch P, Allenet B. Why do patients with chronic inflammatory rheumatic diseases discontinue their biologics? an assessment of patients’ adherence using a self-report questionnaire. The Journal of Rheumatology. 2016;43(4): 724-730. https://doi.org/10.3899/jrheum.150414
Li L, Cui Y, Yin R, Chen S, Zhao Q, Chen H, Shen B. Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Patient Prefer Adherence. 2017;11:1343-1356. https://doi.org/10.2147/PPA.S140457
Pasma A, Schenk CV, Timman R, Busschbach JJ, van den Bemt BJ, Molenaar E, van der Laan WH, Schrauwen S, Van’t Spijker A, Hazes JM. Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease. Arthritis Research and Therapy. 2015;17(1):281.
Bakirov BA, Zaripova GR, Akbuldina KR, Bogdanova JuA, Kudlaj DA. Russian and foreign experience in evaluating adherence to long-term therapy in patients with rheumatoid arthritis: a review of the literature. Therapy. 2019;2:95-103. (In Russ.). https://doi.org/10.18565/therapy.2019.2.95-103